Birmingham, UK: University of Birmingham Enterprise announces the formation of a new spinout company, Viatem Ltd, to develop and exploit the therapeutic potential of PEPITEM (Peptide Inhibitor of Trans-Endothelial Migration).
With a wealth of innovative scientific research emerging from academic institutions and technology transfer offices (TTO) across the UK, it is fair to say that we are truly in a golden age of medical research innovation. As the newly appointed Head of Seed Funds at the medical research charity, LifeArc, I am driven by the question: where does investment and funding of cutting-edge research sit and what role do seed funds play in advancing medical research?
The Cancer Research UK Brain Tumour Awards* have been launched in partnership with The Brain Tumour Charity yesterday (Tuesday 1st May).
This is, in many ways, great news for us in Knowledge Exchange, at the coalface of our university’s relationship with the outside world. The definition of impactful activities and reach should be “deepened and broadened”, which means that the roles of those tasked with developing impact should also be. It is, for some at least, disproportionate in terms of our university’s lack of development of knowledge exchange and impact staff.
Congratulations to Public Health England (PHE)’s Business Development Team for winning the British Expertise International Awards 2018 under “international healthcare project” category for “Fast-track global collaborations to conquer emergencies such as Ebola and Zika”.
PHE’s Senior Business Development Manager Professor Seshadri Vasan collected the award on his team’s behalf from HRH The Duke of Gloucester KG GCVO. It is worth noting that this team also received the 2015 RCUK-PraxisAuril Impact Awards for “contribution to society” for their Ebola response.
This is a unique opportunity to work with two world-class Technology Transfer Offices on a joint internship program and springboard your career into the world of Technology Transfer. Working for six months in Oxford at Oxford University Innovation and in London at Imperial Innovations you will have a once in a lifetime opportunity to work alongside talented and experienced professionals on the following topics:
Brainomix builds on partnership with Boehringer Ingelheim for AI-assisted fast treatment of stroke victims in latest venture round.
Brainomix, a medical imaging company using artificial intelligence (AI) for the fast diagnosis and treatment of stroke victims, has attracted £7m ($9.8m) of investment to bring its software to the global healthcare market.
6D.ai platform uses the built-in smartphone camera to crowdsource real-time, three-dimensional semantic maps of the world.